Skip to main content

AbbVie vs ICICI Bank: Founders, CEOs and History

AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. ICICI Bank was founded in 1994 by Industrial Credit and Investment Corporation of India and is led by Sandeep Bakhshi.

Company facts

AbbVie

Founded
2013
Headquarters
North Chicago, Illinois
Current CEO
Robert A. Michael
Employees
57,000

ICICI Bank

Founded
1994
Headquarters
Mumbai, Maharashtra, India
Current CEO
Sandeep Bakhshi
Employees
124,029

Founders

AbbVie

  • Abbott Laboratories (spin-off origin)

    Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.

AbbVie founders in full

ICICI Bank

  • Industrial Credit and Investment Corporation of India

    The Industrial Credit and Investment Corporation of India (ICICI) was established in 1955 at the initiative of the World Bank, the Government of India, and representatives of Indian industry.

ICICI Bank founders in full

CEOs and their tenures

AbbVie

  1. Richard A. Gonzalez2013–2024

    Founding Chairman and Chief Executive Officer

    Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.

    Source
  2. Robert A. Michael2024–present

    Chairman and Chief Executive Officer

    Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.

    Source
AbbVie CEO history in full

ICICI Bank

  1. K V Kamath1996–2009

    CEO & Managing Director

    Kamath built ICICI's reputation for technology-led banking, early ATMs, internet banking, and retail credit, and oversaw the 2002 reverse merger that created the modern bank.

    Source
  2. Chanda Kochhar2009–2018

    CEO & Managing Director

    Kochhar expanded ICICI Bank's retail franchise and brand reach, but her tenure ended amid the Videocon controversy and a sharp rise in bad corporate loans.

    Source
  3. Sandeep Bakhshi2018–present

    Managing Director & CEO

    Bakhshi is credited with restoring investor and regulator trust after 2018 and turning ICICI Bank into a lower-risk, steadily compounding lender, with net NPAs around 0.3% in 2026.

    Source
ICICI Bank CEO history in full

Timeline: AbbVie and ICICI Bank side by side

  1. 1955ICICI Bank

    ICICI Founded as Development-Finance Institution

    ICICI was formed to provide medium- and long-term project finance to Indian businesses.

  2. 1994ICICI Bank

    ICICI Bank Incorporated

    ICICI Bank was incorporated as part of the ICICI group during India's post-liberalization banking opening. The move gave ICICI a deposit-taking commercial bank able to serve retail, corporate, and transaction-banking customers.

  3. 1999ICICI Bank

    NYSE Listing Milestone

    ICICI became the first Indian company and the first bank or financial institution from non-Japan Asia to list on the New York Stock Exchange. The listing expanded global visibility and imposed a higher disclosure profile on the group.

  4. 2001ICICI Bank

    Bank of Madura Amalgamation

    Bank of Madura was amalgamated with ICICI Bank with effect from March 10, 2001. The deal added branches, customers, and a southern India presence that helped the young bank build distribution faster than organic expansion alone.

  5. 2002ICICI Bank

    Reverse Merger Created Universal Bank

    ICICI, ICICI Personal Financial Services, and ICICI Capital Services merged into ICICI Bank.

  6. 2010ICICI Bank

    Bank of Rajasthan Merger

    The Bank of Rajasthan merger strengthened ICICI Bank's branch network, especially in northern and western India. The transaction mattered because local branches and deposits still supported private-bank scale even as digital channels were growing.

  7. 2013AbbVie

    AbbVie Launches as an Independent Company

    AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.

  8. 2015AbbVie

    Pharmacyclics Acquisition Completed

    AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.

  9. 2018ICICI Bank

    Sandeep Bakhshi Became MD and CEO

    Sandeep Bakhshi became Managing Director and CEO in October 2018 after Chanda Kochhar requested early retirement. His tenure has been associated with a sharper focus on risk controls, asset quality, governance, and steady retail-led growth.

  10. 2019AbbVie

    Skyrizi Receives Initial U.S. Approval

    The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.

  11. 2019AbbVie

    Rinvoq Receives Initial U.S. Approval

    The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.

  12. 2020AbbVie

    Allergan Acquisition Completed

    AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.

  13. 2023AbbVie

    U.S. Humira Biosimilar Competition Begins

    Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.

  14. 2024AbbVie

    ImmunoGen Acquisition Completed

    AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.

  15. 2024AbbVie

    Robert A. Michael Becomes CEO

    Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.

  16. 2024AbbVie

    Cerevel Therapeutics Acquisition Completed

    AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.

  17. 2025AbbVie

    Robert A. Michael Becomes Chairman

    Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.

  18. 2025AbbVie

    FY2025 Revenue Reaches $61.160 Billion

    AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.

  19. 2025ICICI Bank

    FY2025 Balance Sheet Scale

    The FY2025 integrated report listed Rs 16,103.48B in deposits, Rs 13,417.66B in loans and advances, Rs 21,182.40B in standalone total assets, and a 16.55% capital adequacy ratio.

  20. 2025ICICI Bank

    FY2025 Profitability

    ICICI Bank reported Rs 472.27B in standalone profit after tax and Rs 510.29B in consolidated profit after tax for FY2025. Profitability matters because the bank has to fund technology, compliance, provisions, and growth while keeping capital strong.

  21. 2025ICICI Bank

    IMobile and Card Scale

    IMobile processed 558M transactions worth Rs 11,238B in FY2025, and the bank had close to 18M active credit cards at March 31, 2025.

  22. 2026AbbVie

    Q1 2026 Revenue Reaches $15.002 Billion

    AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.

  23. 2026ICICI Bank

    Q1 FY2027 Profit Up 15.9%

    Standalone profit rose 15.9% to Rs 14,805 crore for April-June 2026, with net interest income up 12.7% and net NPAs at 0.35%.

  24. 2026ICICI Bank

    Bakhshi Reappointed to 2028

    The RBI approved Sandeep Bakhshi's reappointment as MD and CEO for two years from October 4, 2026.

  25. 2026ICICI Bank

    FY2026 Profit Crosses Rs 50,000 Crore

    Standalone net profit rose 6.2% to Rs 50,146.6 crore in FY2026, with a 4.32% net interest margin and 15.8% loan growth.

Acquisitions

AbbVie

  • ImmunoGen, Inc.2024$10.1B
  • Cerevel Therapeutics2024$8.7B
  • Allergan plc2020$63B
  • Pharmacyclics, Inc.2015$21B
All AbbVie acquisitions

ICICI Bank

  • Bank of Rajasthan2010Undisclosed
  • The Sangli Bank2007Undisclosed
  • Bank of Madura2001Undisclosed
  • Anagram Finance1998Undisclosed
  • ITC Classic Finance1997Undisclosed
All ICICI Bank acquisitions

Questions about AbbVie vs ICICI Bank

Who is the CEO of AbbVie Inc. and ICICI Bank Limited?

AbbVie Inc. is led by Robert A. Michael and ICICI Bank Limited is led by Sandeep Bakhshi. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.

When was AbbVie Inc. founded vs ICICI Bank Limited?

ICICI Bank Limited was founded in 1994 — 19 years before AbbVie Inc., which was founded in 2013. ICICI Bank Limited's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..

How many employees does AbbVie Inc. have compared to ICICI Bank Limited?

AbbVie Inc. employs approximately 57,000 people, while ICICI Bank Limited employs approximately 124,029. ICICI Bank Limited has the larger workforce at 124,029 employees, compared to AbbVie Inc.'s 57,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).

Where are AbbVie Inc. and ICICI Bank Limited headquartered?

AbbVie Inc. is headquartered in United States and ICICI Bank Limited is headquartered in India. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.

Who founded AbbVie Inc. and ICICI Bank Limited?

AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). ICICI Bank Limited was founded by Industrial Credit and Investment Corporation of India.

Which company has a longer operating history — AbbVie Inc. or ICICI Bank Limited?

ICICI Bank Limited has been operating for approximately 32 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs ICICI Bank overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.